Lohxa LLC is recalling approximately 51 boxes (totaling 1,630 unit dose cups) of Bismuth Subsalicylate and Phenobarbital oral solutions. Bismuth Subsalicylate 262mg/15mL (generic Pepto-Bismol) and Phenobarbital 20 mg/5mL are included in this recall because the packaging labels show incorrect expiration dates. These medications were distributed to Massachusetts, New York, and Wyoming. Because the labeling is inaccurate, patients may inadvertently use the medicine past its safe and effective shelf life, which is particularly concerning for medications used to manage chronic conditions. Consumers should consult with a healthcare professional regarding the safety and effectiveness of their current supply.
Incorrect expiration dates can lead to the use of degraded or ineffective medication. For Phenobarbital, which is used to control seizures, reduced potency could result in a lack of seizure control, posing a significant health risk to the patient.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.